Haemonetics Corporation (HAE) EV/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 21.1 | 1.93 | 18.8 | 18.9 | 19.8 | |||
| Changes by years, y/y, % | -51% | -91% | +873% | -100% | -4.9% | ||||
Haemonetics Corporation. EV/EBITDA
Haemonetics Corporation. EV/EBITDA, changes, %
Haemonetics Corporation (HAE) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q3 | 2024Q4 | 2024Q4 | 2025Q1 | 2025Q2 | LTM ? | |||
| EV/EBITDA | ? | 20.9 | 19.0 | 19.3 | 19.8 | 18.2 | 19.8 | |
| Changes by years, y/y, % | +20% | +4% | +6% | +37% | -15% | |||
| Changes by quarters, q/q, % | -3% | -9% | +2% | +3% | -8% | |||